STEMI resident survival guide: Difference between revisions
Line 61: | Line 61: | ||
{{familytree | | | | | | E01 | | | | | | E01=<div style="float: left; text-align: center; width: 20em; padding:1em;">'''Order labs and tests:'''</div>}} | {{familytree | | | | | | E01 | | | | | | E01=<div style="float: left; text-align: center; width: 20em; padding:1em;">'''Order labs and tests:'''</div>}} | ||
{{familytree | | |,|-|-|-|+|-|-|-|.| | | }} | {{familytree | | |,|-|-|-|+|-|-|-|.| | | }} | ||
{{familytree | | F01 | | F02 | | F03 | | |F01=<div style="float: left; text-align: left; width: 15em; padding:1em;"> '''[[EKG]]'''<br> | {{familytree | | F01 | | F02 | | F03 | | |F01= <div style="float: left; text-align: left; width: 15em; padding:1em;">'''[[EKG]]'''<br> ❑ New ST elevation at the J point in at least 2 contiguous leads of 2 mm (0.2 mV) in men or 1.5 mm (0.15 mV) in women in leads V2–V3 and/or of 1 mm (0.1 | ||
:❑ Troponin I<br> | mV) in other contiguous chest leads or the limb leads</div> | F02=<div style="float: left; text-align: left; width: 15em; padding:1em;"> '''[[Cardiac Enzymes]]''' <br> | ||
:❑ Troponin I (preferred biomarker) <br> | |||
:❑ CK-MB </div> | :❑ CK-MB </div> | ||
|F03=<div style="float: left; text-align: left; width: 15em; padding:1em;">'''Other labs:''' <br> | |F03=<div style="float: left; text-align: left; width: 15em; padding:1em;">'''Other labs:''' <br> |
Revision as of 17:34, 3 March 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]
Definition
ST elevation myocardial infarction (STEMI) is a syndrome defined by symptoms of myocardial ischemia (sudden chest pain and pressure, shortness of breath) associated with persistent ECG ST elevation and subsequent release of cardiac enzymes.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. STEMI is a life-threatening condition and must be treated as such irrespective of the causes.
Common Causes
- Rupture of high-risk plaque in the coronary arteries
- Occlusive Thrombus
Management
Diagnostic Approach
Shown below is an algorithm summarizing the diagnostic approach to STEMI based on the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction[1]
Characterize the symptoms:
❑ Diaphoresis | |||||||||||||||||||||||||||
Obtain a detailed history: ❑ Age
| |||||||||||||||||||||||||||
Examine the patient: ❑ Measure the blood pressure
| |||||||||||||||||||||||||||
Rule out life threatening alternative diagnoses: ❑ Aortic dissection | |||||||||||||||||||||||||||
Order labs and tests: | |||||||||||||||||||||||||||
EKG ❑ New ST elevation at the J point in at least 2 contiguous leads of 2 mm (0.2 mV) in men or 1.5 mm (0.15 mV) in women in leads V2–V3 and/or of 1 mm (0.1 mV) in other contiguous chest leads or the limb leads | |||||||||||||||||||||||||||
Therapeutic Apporach
Shown below is an algorithm summarizing the therapeutic approach to STEMI based on the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
References
- ↑ O'Gara, Patrick T.; Kushner, Frederick G.; Ascheim, Deborah D.; Casey, Donald E.; Chung, Mina K.; de Lemos, James A.; Ettinger, Steven M.; Fang, James C.; Fesmire, Francis M.; Franklin, Barry A.; Granger, Christopher B.; Krumholz, Harlan M.; Linderbaum, Jane A.; Morrow, David A.; Newby, L. Kristin; Ornato, Joseph P.; Ou, Narith; Radford, Martha J.; Tamis-Holland, Jacqueline E.; Tommaso, Carl L.; Tracy, Cynthia M.; Woo, Y. Joseph; Zhao, David X. (2013). "2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction". Journal of the American College of Cardiology. 61 (4): e78–e140. doi:10.1016/j.jacc.2012.11.019. ISSN 0735-1097.